Aminoalkylphosphonates and related compounds as edg receptor agonists

   
   

The present invention encompasses compounds of formula (II); as well as the pharmaceutically acceptable salts and hydrates thereof. The compounds are useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. Pharmaceutical compositions and methods of use are included. 1

 
Web www.patentalert.com

< Diphenylethylene compounds and uses thereof

< Cloning using donor nuclei from differentiated fetal and adult cells

> Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists

> New inhibitors of histone deacetylase

~ 00182